Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) EPS (Weighted Average and Diluted) (2016 - 2025)

Bio-Techne (TECH) has 17 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.24 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 14.29% year-over-year to $0.24; the TTM value through Dec 2025 reached $0.52, down 47.47%, while the annual FY2025 figure was $0.46, 56.19% down from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.24 in Q4 2025 per TECH's latest filing, roughly flat from $0.24 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.94 in Q4 2021 and bottomed at -$2.24 in Q2 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.41, with a median of $0.31 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): crashed 250.34% in 2021, then surged 116.96% in 2022.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $1.94 in 2021, then crashed by 84.02% to $0.31 in 2022, then crashed by 45.16% to $0.17 in 2023, then grew by 23.53% to $0.21 in 2024, then rose by 14.29% to $0.24 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.24 in Q4 2025, $0.24 in Q3 2025, and -$0.1 in Q2 2025.